Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

My Patient May Have a Mitochondrial Disease: What Should I Do?

Published: Fri, 17 Aug 2018 10:28:56 EDT
All patients with a suspected mitochondrial disease should be seen by a mitochondrial medicine expert. But what can the primary care clinician do while waiting for that to happen?
CHOP Expert Commentary

In HIV, Viral Load Matters and PrEP Is Still Critical

Published: Fri, 17 Aug 2018 10:10:46 EDT
Some good news for HIV patients with a suppressed viral load.
Medscape Internal Medicine

Biologic Agents Are Changing the Landscape of Severe Asthma

Published: Fri, 17 Aug 2018 10:01:00 EDT
A fourth biologic for severe eosinophilic asthma may soon be available. Who is a candidate for this therapy and what effects can you expect?
Medscape Pulmonary Medicine

FDA Grants 510(k) Clearance to New Spinal Implant

Published: Fri, 17 Aug 2018 09:52:25 EDT
The Foundation 3D anterior lumbar interbody cage implant uses CoreLink's proprietary mimetic metal technology, which mimics key characteristics of natural bone.
FDA Approvals
Displaying results 13-16 (of 20)
 1 - 2 - 3 - 4 - 5 


Andrew Cheng to quit Gilead 6 months after taking CMO post

Published: Wed, 15 Aug 2018 09:11:59 +0000
Andrew Cheng is set to leave Gilead six months after being appointed CMO. Cheng’s swift exit keeps the revolving door spinning at the top of Gilead, which is set to lose its CEO, CMO, CSO and executive chairman over a nine-month window.

How elephants resist cancer by reviving a ‘zombie’ gene

Published: Tue, 14 Aug 2018 17:09:55 +0000
Researchers at the University of Chicago have discovered that in elephants, the tumor-suppressor gene p53 awakens a dormant gene, which goes on to kill cancer precursor cells. They believe the discovery could be used to develop drugs that mimic this process.

Insilico, Juvenescence and the Buck Institute form AI-based venture to tackle metabolism and aging-related diseases

Published: Tue, 14 Aug 2018 13:48:18 +0000
A triumvirate of aging-focused biotechs and researchers—the AI company Insilico Medicine, the portfolio-based startup Juvenescence and the nonprofit Buck Institute—have formed a new joint venture to develop small molecules for a novel target in a bid to extend life spans.

Batycky exits Acorda to head up new biotech

Published: Tue, 14 Aug 2018 13:05:00 +0000
Acorda Therapeutics’ chief technology officer, Rick Batycky, Ph.D., is leaving the company next week after four years in the role to head up his own operation.
Displaying results 13-16 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy